Your shopping cart is empty!
PDF Preview
Clinical and Laboratory Standards Institute, 11/01/2022
Publisher: CLSI
File Format: PDF
$25.00$50.00
Published:01/11/2022
Pages:14
File Size:1 file , 920 KB
Note:This product is unavailable in Russia, Belarus
This implementation guide describes the minimum procedures necessary for a medical laboratory to verify that new reagent lots, when received and implemented by the laboratory, will produce results consistent with previous reagent lots. Reagent lot performance is validated by the developer before release and distribution; however, the laboratory needs to verify each new reagent lot it receives. Changes in performance with a new reagent lot could be due to: • Changes in reagent component materials • Instability of a component in a reagent • Reagents that were compromised in transportation or storage • Incorrect calibration of the new reagent lot
Verifying that these potential changes have not occurred is important to ensure the quality of laboratory results. For additional information on the acceptability of a reagent lot change, see CLSI document EP26.1
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2
$109.00 $219.97
Laboratory Automation: Systems Operational Requirements, Characteristics, and Information Elements; Approved Standard, AUTO04AE
$107.00 $214.51
Laboratory Automation: Electromechanical Interfaces; Approved Standard, AUTO05AE
$125.00 $250.90
Laboratory Automation: Communications with Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems; Approved Standard, AUTO3-A
$107.00 $215.38